MRS25-02
CIBMTR Validation of the Transplant Conditioning Intensity (TCI) Classification System in Patients with Acute Myeloid Leukemia and Myelodysplastic Syndrome receiving GVHD prophylaxis with or without Post-Transplant Cyclophosphamide
Study #: MRS25-02
Study Status: Protocol Development
